Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Background</h3><p>To investigate antibiotic resistance of pathogens responsible for neonatal invasive bacterial infections(IBIs) in China.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>Cross-sectional study of neonates with IBI evaluated in nine hospitals in China (January 2012 - August 2019). Antibiotic resistance patterns of pathogens responsible for neonatal IBIs were analyzed.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>Of 3770 full-term neonates who were subjected to lumbar puncture and a blood culture, IBIs were diagnosed in 460 neonates (12.2%). <em>Escherichia coli</em> and Group B <em>Streptococcus</em> (GBS) were the leading pathogens, followed by <em>Enterococcus spp</em>, and <em>Staphylococcus aureus</em>. <em>Escherichia coli</em> expressed high resistance to ampicillin (72.0%) and third-generation cephalosporins (cefotaxime, 34.8%; ceftriaxone, 38.1%). The prevalence of extended spectrum beta-lactamase (ESBL)-producing <em>Escherichia coli</em> was 34.1%. The proportions of <em>Enterococcus spp</em> resistant to penicillin and ampicillin were 60% and 54.1%. All <em>Staphylococcus aureus</em> showed resistance to ampicillin and penicillin. The resistance rate of <em>Staphylococcus aureus</em> to methicillin was 50%. Although all GBS were susceptible to penicillin and ampicillin, the proportions of GBS resistant to erythromycin and clindamycin were 75.9% and 77.3%. Antibiotic susceptibility appeared to improve in 2019. Susceptibility of <em>Escherichia coli</em> to ampicillin, cefotaxime, and ceftriaxone improved to 42.9%, 76.9%, and 71.4% in 2019, compared with 12.5%, 37.5%, and 50% in 2012. The prevalence of ESBL-producing <em>Escherichia coli</em> declined to 20% in 2019, lower than 100% in 2012. Susceptibility of GBS to erythromycin and clindamycin improved from 0% in 2012 to 28.6% and 25% in 2019.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusions</h3><p>The prevalence of antibiotic resistance is high in neonates in China, although there is a favorable declining trend in recent years.</p>

Antibiotic resistance in neonates in China 2012–2019: A multicenter study